Accelerating Drug Safety Assessment using Bidirectional-LSTM for SMILES Data
0
📊
Sign in to get full access
Overview
- Computational methods can accelerate drug discovery, which involves several steps like target identification, lead discovery, and lead optimization.
- Lead optimization focuses on assessing the absorption, distribution, metabolism, excretion, and toxicity (ADME/T) properties of lead compounds.
- To predict the toxicity and solubility of lead compounds represented in Simplified Molecular Input Line Entry System (SMILES) notation, a sequence-based approach is proposed.
- The proposed Bi-Directional Long Short Term Memory (BiLSTM) model, a variant of Recurrent Neural Network (RNN), processes input molecular sequences to examine structural features from both forward and backward directions.
- The goal is to understand the sequential patterns encoded in SMILES strings and use them to predict the toxicity and solubility of molecules.
Plain English Explanation
Developing new drugs is a complex and time-consuming process. Computational methods can help speed things up by automating certain steps. One important step is lead optimization, where researchers assess how well a potential drug compound is absorbed, distributed, metabolized, excreted, and its toxicity (ADME/T).
The researchers in this study focused on predicting the toxicity and solubility of drug compounds, which are represented using a special code called SMILES. They developed a machine learning model called Bi-Directional Long Short Term Memory (BiLSTM) that can analyze the SMILES code to understand the structure and properties of the drug compound.
The BiLSTM model looks at the SMILES code from both the beginning and the end, kind of like reading a book forwards and backwards. This helps it get a more complete understanding of the compound's structure. The researchers found that their BiLSTM model outperformed previous approaches in accurately predicting the toxicity and solubility of drug compounds.
By improving the ability to predict these important properties, the BiLSTM model can help researchers identify promising drug candidates more efficiently and speed up the overall drug discovery process.
Technical Explanation
The proposed model uses a sequence-based approach to predict the toxicity and solubility of drug compounds represented in SMILES notation. The key component is the Bi-Directional Long Short Term Memory (BiLSTM) architecture, a variant of Recurrent Neural Networks (RNNs).
RNNs are well-suited for processing sequential data, like the SMILES strings that encode molecular structures. The BiLSTM model enhances the standard LSTM by processing the input sequence in both the forward and backward directions. This allows the model to examine the structural features of the molecules more comprehensively.
The proposed BiLSTM model was evaluated on two benchmark datasets: ClinTox for toxicity prediction and FreeSolv for solubility prediction. On the ClinTox dataset, the BiLSTM model achieved a ROC accuracy of 0.96, outperforming previous approaches like Trimnet and Pre-training Graph Neural Networks (GNNs). For the FreeSolv dataset, the BiLSTM model achieved a low RMSE of 1.22 in solubility prediction, surpassing prior models.
Critical Analysis
The study demonstrates the effectiveness of the BiLSTM architecture in capturing the sequential patterns in SMILES strings to predict the toxicity and solubility of drug compounds. However, the paper does not provide detailed information about the model's training hyperparameters, dataset sizes, or the diversity of the compounds used.
Additionally, the paper does not discuss the potential limitations of the BiLSTM approach, such as its ability to generalize to more complex molecular structures or its performance on larger, more diverse datasets. Further research is needed to explore the model's robustness and applicability to real-world drug discovery challenges.
It would also be beneficial to understand how the BiLSTM model's predictions compare to experimental data or other computational methods that consider the 3D structure of molecules, which may provide complementary information to the 1D SMILES representation.
Conclusion
The proposed BiLSTM model demonstrates the power of sequence-based approaches in accelerating the drug discovery process by accurately predicting the toxicity and solubility of drug compounds from their SMILES representations. By outperforming previous methods, the BiLSTM model shows promise in helping researchers identify promising drug candidates more efficiently.
However, further research is needed to fully understand the model's limitations and explore its integration with other computational techniques to provide a more comprehensive solution for drug discovery. As computational methods continue to advance, they will play an increasingly important role in transforming the way new drugs are developed.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
📊
0
Accelerating Drug Safety Assessment using Bidirectional-LSTM for SMILES Data
K. Venkateswara Rao, Dr. Kunjam Nageswara Rao, Dr. G. Sita Ratnam
Computational methods are useful in accelerating the pace of drug discovery. Drug discovery carries several steps such as target identification and validation, lead discovery, and lead optimisation etc., In the phase of lead optimisation, the absorption, distribution, metabolism, excretion, and toxicity properties of lead compounds are assessed. To address the issue of predicting toxicity and solubility in the lead compounds, represented in Simplified Molecular Input Line Entry System (SMILES) notation. Among the different approaches that work on SMILES data, the proposed model was built using a sequence-based approach. The proposed Bi-Directional Long Short Term Memory (BiLSTM) is a variant of Recurrent Neural Network (RNN) that processes input molecular sequences for the comprehensive examination of the structural features of molecules from both forward and backward directions. The proposed work aims to understand the sequential patterns encoded in the SMILES strings, which are then utilised for predicting the toxicity of the molecules. The proposed model on the ClinTox dataset surpasses previous approaches such as Trimnet and Pre-training Graph neural networks(GNN) by achieving a ROC accuracy of 0.96. BiLSTM outperforms the previous model on FreeSolv dataset with a low RMSE value of 1.22 in solubility prediction.
Read more7/30/2024
0
SMILES-Mamba: Chemical Mamba Foundation Models for Drug ADMET Prediction
Bohao Xu, Yingzhou Lu, Chenhao Li, Ling Yue, Xiao Wang, Nan Hao, Tianfan Fu, Jim Chen
In drug discovery, predicting the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small-molecule drugs is critical for ensuring safety and efficacy. However, the process of accurately predicting these properties is often resource-intensive and requires extensive experimental data. To address this challenge, we propose SMILES-Mamba, a two-stage model that leverages both unlabeled and labeled data through a combination of self-supervised pretraining and fine-tuning strategies. The model first pre-trains on a large corpus of unlabeled SMILES strings to capture the underlying chemical structure and relationships, before being fine-tuned on smaller, labeled datasets specific to ADMET tasks. Our results demonstrate that SMILES-Mamba exhibits competitive performance across 22 ADMET datasets, achieving the highest score in 14 tasks, highlighting the potential of self-supervised learning in improving molecular property prediction. This approach not only enhances prediction accuracy but also reduces the dependence on large, labeled datasets, offering a promising direction for future research in drug discovery.
Read more8/13/2024
0
Accelerating the inference of string generation-based chemical reaction models for industrial applications
Mikhail Andronov, Natalia Andronova, Michael Wand, Jurgen Schmidhuber, Djork-Arn'e Clevert
Template-free SMILES-to-SMILES translation models for reaction prediction and single-step retrosynthesis are of interest for industrial applications in computer-aided synthesis planning systems due to their state-of-the-art accuracy. However, they suffer from slow inference speed. We present a method to accelerate inference in autoregressive SMILES generators through speculative decoding by copying query string subsequences into target strings in the right places. We apply our method to the molecular transformer implemented in Pytorch Lightning and achieve over 3X faster inference in reaction prediction and single-step retrosynthesis, with no loss in accuracy.
Read more7/18/2024
0
MolX: Enhancing Large Language Models for Molecular Learning with A Multi-Modal Extension
Khiem Le, Zhichun Guo, Kaiwen Dong, Xiaobao Huang, Bozhao Nan, Roshni Iyer, Xiangliang Zhang, Olaf Wiest, Wei Wang, Nitesh V. Chawla
Large Language Models (LLMs) with their strong task-handling capabilities have shown remarkable advancements across a spectrum of fields, moving beyond natural language understanding. However, their proficiency within the chemistry domain remains restricted, especially in solving professional molecule-related tasks. This challenge is attributed to their inherent limitations in comprehending molecules using only common textual representations, i.e., SMILES strings. In this study, we seek to enhance the ability of LLMs to comprehend molecules by equipping them with a multi-modal external module, namely MolX. In particular, instead of directly using a SMILES string to represent a molecule, we utilize specific encoders to extract fine-grained features from both SMILES string and 2D molecular graph representations for feeding into an LLM. Moreover, a handcrafted molecular fingerprint is incorporated to leverage its embedded domain knowledge. Then, to establish an alignment between MolX and the LLM's textual input space, the whole model in which the LLM is frozen, is pre-trained with a versatile strategy including a diverse set of tasks. Experimental evaluations show that our proposed method outperforms baselines across 4 downstream molecule-related tasks ranging from molecule-to-text translation to retrosynthesis, with and without fine-tuning the LLM, while only introducing a small number of trainable parameters 0.53% and 0.82%, respectively.
Read more8/23/2024